Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    More from Day One of GRx+Biosims 2026

    We heard from Michael Kopcha, PhD, RPh, Director, Office of Pharmaceut...
    Read More
    A Few Tidbits from the Generic Drugs Forum (GDF) 2026 Morning Sessions

    GRx+Biosims 2026 – Some Tidbits from Day 1 of the Conference

    Opening remarks from John Murphy III, CEO and President of the Associa...
    Read More
    One More Extension for DESI Estrogen-Androgen Fixed Combination Drug Products

    One More Extension for DESI Estrogen-Androgen Fixed Combination Drug Products

    Today, notice of the third extension of the “final” DESI notice ap...
    Read More

    HHS Breaks with FDA Scientists on 503A Peptide Compounding

    Despite the FDA’s stated views at the compounding advisory committee...
    Read More

    Another FDA Warning Regarding Hidden Ingredients – This One Has Some History

    In an advisory published yesterday (here), FDA is warning consumers no...
    Read More

    Q&A Guidance on Mandatory Cosmetic Recall Provisions

    At the end of December 2022, “the President signed into law the Cons...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today